Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

GPCR

NASDAQ

Structure Therapeutics (GPCR)

21.17 USD −3.66% vs prior close Oct 23, 2026
Structure Therapeutics Inc. price graph
26 sessions
40 20 18 Sep 23 Oct

The line runs 35 USD on 18 September through 21.17 USD on 23 October, on a scale from 20 to 40. Days the market did not trade hold the previous close, flat.

Market cap
4.5B USD
EPS, diluted, year to Dec 2025
−0.80 USD
Avg volume
77.6K

as of Oct 23, 2026

Have Structure Therapeutics (GPCR) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, no Structure Therapeutics insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Form 4, 90 days to 22 Nov 2026, newest Form 4 filing 21 Sep 2026

0buys
0sells
4other filings
Have Structure Therapeutics (GPCR) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
21 Sep 2026Coll Crespo BlasCHIEF MEDICAL OFFICEROther12,024
18 Sep 2026Coll Crespo BlasCHIEF MEDICAL OFFICERTax withheld10,626124K USD
01 Sep 2026Lin XichenCHIEF SCIENTIFIC OFFICEROption exercise17,8176K USD
01 Sep 2026Lin XichenCHIEF SCIENTIFIC OFFICEROther17,817

Which funds hold Structure Therapeutics (GPCR)?

7 of the 45 institutional funds we track reported a Structure Therapeutics position for the quarter ended 30 Sep 2026 — a combined 72.2M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Structure Therapeutics (GPCR)?
FundPositionSharesValueShares q/q
Baker Bros. AdvisorsHeld (±25%)1,432,52944.8M USD
Two Sigma InvestmentsAdded442,10713.8M USD+116.6%
Citadel AdvisorsNew position116,2953.6M USD
D. E. Shaw & Co.Held (±25%)115,3003.6M USD
Marshall WaceTrimmed108,3663.4M USD−59.5%
Millennium ManagementHeld (±25%)80,6752.5M USD−9.9%
Tudor Investment CorpTrimmed12,639395K USD−76.4%

What has been filed or recorded for Structure Therapeutics (GPCR)?

The filings we hold for Structure Therapeutics, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 20 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Structure Therapeutics (GPCR)?
And
20 Oct 2026Fails to deliverShares failed to deliver42,724 shares940K USD notional · 0.020% of shares out
14 Oct 2026Fails to deliverShares failed to deliver3,299 shares74K USD notional · 0.002% of shares out
13 Oct 2026Fails to deliverShares failed to deliver912 shares22K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver30 shares770 USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.66 USD
30 Sep 2026FinancialsTotal assets1.3B USDat period end
30 Sep 2026FinancialsTotal equity1.2B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.49 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.35 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −0.80 USD
31 Dec 2025FinancialsNet income−141.2M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.80 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.37 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.36 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.27 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −0.78 USD

What do people ask about Structure Therapeutics (GPCR)?

From live data
What did Structure Therapeutics shares close at?21.17

Structure Therapeutics closed at 21.17 USD on 23 Oct 2026, down 3.66% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Structure Therapeutics’ market cap?4.5B

Structure Therapeutics is worth 4.5B USD by market value as of 23 Oct 2026, which is the share price times the shares on issue from its SEC filings.

Have Structure Therapeutics insiders bought or sold shares recently?4 filings

In the 90 days to 22 Nov 2026, no Structure Therapeutics insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders

Which funds own Structure Therapeutics?7 of 45

7 of the 45 funds we track reported a Structure Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Baker Bros. Advisors, Two Sigma Investments and Citadel Advisors. See Funds

When did Structure Therapeutics last report earnings?−0.66

Structure Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.66 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words